Stand up for facts and support PolitiFact.
Now is your chance to go on the record as supporting trusted, factual information by joining PolitiFact’s Truth Squad. Contributions or gifts to PolitiFact, which is part of the 501(c)(3) nonprofit Poynter Institute, are tax deductible.
I would like to contribute
State lawmakers have a month before they get back to work in the 2015 legislative session and already the debate over medical marijuana has gotten into the, ahem, weeds.
State Rep. Allen Peake, R-Macon serves as co-chair of a joint legislative committee that has studied whether and how to legalize the drug for certain conditions, including seizures in children.
Peake has revived a bill aimed at allowing cannabis oil made from marijuana plants for treatment of certain seizure disorders and other health problems. He is finalizing that proposal, pre-filed as House Bill 1 after a similar measure fell short last session.
But another committee member, state Sen. Curt Thompson, D-Tucker, is proposing a competing bill that would allow vaporized, edible or smokable marijuana. Thompson also has filed a resolution, calling for a statewide referendum on whether to authorize recreational use of the drug.
Confusion about the oil form versus a smokeable drug has prompted Peake, who said he does not support expanded use, to speak out.
"We believe that the medical cannabis oil – very low in THC, that doesn’t have a psychoactive component to it, cannot get you high – is a better approach for our citizens," Peake said in a press conference before a committee meeting last week.
Opponents of the oil have raised safety concerns. So PolitiFact Georgia decided to take a closer look at Peake’s contention that the oil extracted from marijuana won’t get users high.
First, a reminder that the federal government still classifies marijuana as a Schedule I substance, defined as "the most dangerous" drug "with no currently accepted medical use."
Despite that designation, 23 states have legalized medical marijuana, allowing access to the drug for a variety of medical conditions.
Another 11 states – including neighboring Alabama, Florida, North Carolina, South Carolina and Tennessee – have enacted laws allowing cannabis oil products for medical reasons in limited situations.
The key difference in allowing the oil, supporters say, is that it is high in cannabidiol and low in tetrahydrocannabinol.
Both are compounds found in the marijuana plant that act on cell receptors that control neurotransmitters in the brain and the immune system from various organs, such as the spleen.
Cannabidiol, known as CBD, is an antioxidant and not psychoactive. Tetrahydrocannabinol or THC is the long-known mind-altering part of pot.
Cannabis oil is made from strains of marijuana already bred to be high in CBD and low in THC. For medical use, the oil is made with less than 3 percent THC and is orally ingested. Children’s doses tend to be at 1 percent THC, or lower.
Studies are scarce on the medical benefits of such a product, given the Schedule I classification.
But research does show that THC is what brings both it and CBD into the brain, where CBD’s antioxidant properties are thought to protect the brain.
That evidence helped the federal Department of Health and Human Services earn a patent on medical marijuana in 2003.
Anecdotally, parents of children with epilepsy and other seizure diseases back up the findings, reporting marked improvement from the cannabis oil.
A London drug company, GW Pharmaceuticals, has created a drug out of highly purified CBD that has shown in preclinical studies that it potentially reduce seizures.
The firm is waiting on final approval from Georgia Regents University and the federal Drug Enforcement Administration to begin clinical trials in Georgia with children who have severe seizure disorders.
None of the existing studies or anecdotes from parents acknowledge or report any "high" from cannabis oil.
Even the National Institute on Drug Abuse, while acknowledging the federal government does not see marijuana as medicine, reports that CBD as a "non-psychoactive cannabinoid" that may prove useful in treating epilepsy as well as some inflamation disorders and mental illnesses.
In other words, while the medical use of cannabis oil can be debated given the limited number of medical and clinic studies, there is some common ground on the product.
Marijuana remains officially a more dangerous drug than cocaine, according to the federal government.
But the main component of the plant used to make cannabis oil doesn’t have the mind-altering, munchies-inducing effect associated with street use of the plant.
We rate Peake’s statement True.
State Rep. Allen Peake, R-Macon, press conference, State Capitol, Dec. 3, 2014
U.S Drug Enforcement Administration, Drug Schedules, accessed Dec. 4, 2014
National Conference of State Legislatures,State Medical Marijuana Laws, accessed Dec. 4, 2014
U.S. Patent Office, Patent No. 6630507, Cannabinoid usage limiting neurological damage, Oct. 7, 20013
National Institutes of Health, Medical Uses of Cannabis, Oct. 25, 2012
National Cancer Institute, Cannabis and Cannabinoids, accessed Dec. 3, 2014
National Institute on Drug Abuse, "Is Marijuana Medicine?," April 2014
Augusta Chronicle, "Cannabis oil clinical trial at Georgia Regents University might not be only option," Nov. 12, 2014
CBS Denver, "Epilepsy patients flock to Colorado after medical pot gives them hope," Nov. 18, 2013
Medscape, "FDA Approves Cannabis Extract Study in Pediatric Epilepsy," Dec. 12, 2013
Read About Our Process
In a world of wild talk and fake news, help us stand up for the facts.